Conference Coverage

Mass Psychogenic Illness: Risk Factors and Treatment


 

—Jake Remaly

Suggested Reading

Bartholomew RE, Wessely S, Rubin GJ. Mass psychogenic illness and the social network: is it changing the pattern of outbreaks? J R Soc Med. 2012;105(12):509-512.

Broderick JE, Kaplan-Liss E, Bass E. Experimental induction of psychogenic illness in the context of a medical event and media exposure. Am J Disaster Med. 2011;6(3):163-172.

Page LA, Keshishian C, Leonardi G, et al. Frequency and predictors of mass psychogenic illness. Epidemiology. 2010;21(5):744-747.

Roach ES, Langley RL. Episodic neurological dysfunction due to mass hysteria. Arch Neurol. 2004;61(8):1269-1272.

Pages

Recommended Reading

Fenfluramine Reduces Convulsive Seizure Frequency in Dravet Syndrome
MDedge Neurology
Cardiosphere-derived cells may reverse Duchenne heart scarring
MDedge Neurology
Gene Replacement Improves Survival in Spinal Muscular Atrophy
MDedge Neurology
Nondrug Treatments May Benefit Patients With Epilepsy
MDedge Neurology
Surgery or Medical Management for Refractory Pediatric Epilepsy?
MDedge Neurology
Genetic Screens Yield Potential Therapies for Neurodegenerative Diseases
MDedge Neurology
Persistent opioid use a risk after surgery in teens and young adults
MDedge Neurology
Junk food, energy drinks may damage teen brains
MDedge Neurology
Nutrition early in life has long-term effects on neurodevelopment
MDedge Neurology
Study finds rising use of newer DMTs in pediatric-onset MS
MDedge Neurology

Related Articles